NOTE 14 – BUSINESS CONCENTRATIONS (Details Narrative)	6 Months Ended
	Jun. 30, 2020 USD ($) Number	Jun. 30, 2019 USD ($) Number
Supplier One Concentration Risk [Member]
Concentration Risk [Line Items]
Concentration risk	18.00%	14.00%
Supplier 2
Concentration Risk [Line Items]
Concentration risk	36.00%	18.00%
Supplier 3
Concentration Risk [Line Items]
Concentration risk	39.00%	31.00%
Supplier Four Concentration Risk [Member]
Concentration Risk [Line Items]
Concentration risk		37.00%
Customer Concentration Risk [Member] | Revenue Benchmark [Member]
Concentration Risk [Line Items]
Concentration risk	10.00%	10.00%
Number of customers - revenue | Number	4	3
Four Customers Concentration Risk Member | Revenue Benchmark [Member]
Concentration Risk [Line Items]
Concentration risk	70.00%
Three Customers Concentration Risk Member | Revenue Benchmark [Member]
Concentration Risk [Line Items]
Concentration risk		60.00%
PillPack - Major Customer | Revenue Benchmark [Member]
Concentration Risk [Line Items]
Revenues	$ 5,707,000	$ 3,615,000
Cardinal Health - Major Customer | Revenue Benchmark [Member]
Concentration Risk [Line Items]
Revenues	3,772,000	1,048,000
McKesson Corporation - Major Customer | Revenue Benchmark [Member]
Concentration Risk [Line Items]
Revenues	3,356,000
Pharmacy Innovations PA - Major Customer | Revenue Benchmark [Member]
Concentration Risk [Line Items]
Revenues	$ 3,178,000
AmerisourceBergen - Major Customer | Revenue Benchmark [Member]
Concentration Risk [Line Items]
Revenues		$ 1,365,000